Seven companies have been awarded scientific and technological innovation duty-free import qualification designations by the foreign R&D center in Pudong New Area. Among the awardees are Fosun Kite Biotechnology Co., Ltd, a joint venture (JV) between Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) and Gilead subsidiary Kite Pharma, as well as Siemens Healthineers. This recognition highlights the commitment of Pudong New Area to fostering innovation and supporting the growth of foreign R&D centers in the region.
Support for Foreign R&D Centers
The foreign R&D center is a crucial component of China’s industrial development and science and technology innovation system. The Pudong New Area government actively supports the establishment of foreign-funded R&D centers and open innovation platforms. This support includes measures to:
- Encourage the establishment of foreign-funded global R&D centers
- Facilitate the identification and recognition of foreign-funded R&D centers
- Optimize the tax-free qualification of foreign-funded R&D centers
- Strengthen the protection of intellectual property rights
- Optimize foreign talent services and improve the talent introduction mechanism
- Support the construction of scientific and technological innovation center platforms
- Enhance the convenience of R&D supplies and materials
These initiatives are designed to create a conducive environment for foreign R&D centers, promoting innovation and technological advancement in Pudong New Area.-Fineline Info & Tech
